Dem Bundesamt für Sicherheit im Gesundheitswesen (BASG) wurde von der griechischen Behörde mitgeteilt, dass in Griechenland, in den Regionen Athen-Nord und Ostattika bestätigte humane WNV-Infektion verzeichnet wurde.

Referenced at:

• Update: West Nile virus (WNV) – Greece

Risk for fixed drug eruption. Further information and amendments to the product information can be found on the EMA website.

• attach_file
  Mustertext Röntgenkontrastmittel | 324 KB
• link
  Link to the EMA Website

Risk for neurodevelopmental disorders with paternal exposure. Further information and amendments to the product information can be found on the EMA website.

• attach_file
  Mustertext Valproat | 341 KB
• link
  Link to the EMA Website

Risk for drug reaction with eosinophilia and systemic symptoms (DRESS). Further information and amendments to the product information can be found on the EMA website.

• attach_file
  Mustertext Gemcitabin | 411 KB
• link
  Link to the EMA Website

Transfer of ownership Transfer of ownership - Transfer of title for a marketing authorisation/registration from the current marketing authorisation/registration holder to a new one New AFTER authorisa

Risk for infection due to viral transmission. Further information and amendments to the product information can be found on the EMA website.

• attach_file
  Mustertext Pankreatin | 382 KB
• link
  Link to the EMA Website

Further information and amendments to the product information in all EU languages are available on the EMA website.

• link
  Link to the EMA Website